PolyPid Ltd. (PYPD)
NASDAQ·Healthcare·Biotechnology
$4.67
+2.19%
Mkt Cap $42.60M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$9.50
Range $9.00 – $10.00
Implied Upside
+103.4%
Consensus $9.50 vs current $4.67
NASDAQ·Healthcare·Biotechnology
$4.67
+2.19%
Mkt Cap $42.60M
No recent rating data.
Price Target (2 analysts)
$9.50
Range $9.00 – $10.00
+103.4%
Consensus $9.50 vs current $4.67